@article{Zampieron_Sheng_Gama_Rissato_Leitzke_2021, title={Home pharmaceutical service in Sinop/MT}, volume={14}, url={https://sea.ufr.edu.br/SEA/article/view/1189}, DOI={10.36560/14120211189}, abstractNote={<p>The home pharmaceutical service is a type of pharmaceutical assistance common in several municipalities in the country, whether private or public. The objective of this study was to track chronic diseases, with emphasis on diabetes, obesity, hypertension, during home pharmaceutical services. During the consultations, which were random and concentrated in a neighborhood of Sinop-MT, a form was applied. During visits, clinical parameters were measured, such as: blood pressure; body index; abdominal circumference; glycemia; Findrisc score for diabetes mellitus; and any other illnesses that the patient was affected at that time, that is, the patient’s current history of illness. The study was characterized by a quantitative and experimental methodological approach, such as field and intervention research. The study involved 19 households and 30 patients, occurring between September 25, 2019 to January 31, 2020. Of the total, 36.7% (n = 11) had hyperglycemia. When assessing BMI (Body Mass Index), 30.0% (n = 9) were overweight and 23.3% (n = 7) were obese; abdominal circumference (WC) in 36.7% (n = 11) suggested a high risk for the development of obesity; 26.6% (n = 8) were hypertensive. Seven patients (23.3%) were self-monitoring for diabetes, obesity and blood pressure. In the Findrisc Survey for risk factors for type 2 diabetes mellitus, 20.0% (n = 6) were classified as high risk and very high risk. The distribution in the age group was 33.3% (n = 10) for age <45 years and 66.7% (n = 20) for age> 45 years. Still, the responses to the questionnaire showed that 23.3% (n = 7) of patients declared a family history for diabetes. In the tracking of illnesses, there was an emphasis on type diabetes mellitus (20%; n = 7); obesity (20.0%; n = 7); hypertension (16.6%; n = 6); insomnia / anxiety (16.6%; n = 6); and dyslipidemia (8.4%; n = 3). Drug interactions were not observed in polypharmacy, a practice with a prescription rate of 22.2% (n = 4). With this study it was possible to discuss the role of the pharmacist with the team of the Family Health Assistance Center in tracking chronic diseases present in the population. Thus, it is possible to correlate these findings with the incident diseases, providing the future pharmaceutical professional with greater involvement in caring for his community and being able to act in maintaining health and with a sense of social responsibility.</p>}, number={1}, journal={Scientific Electronic Archives}, author={Zampieron, R. G. and Sheng, L. Y. and Gama, G. A. and Rissato, M. A. R. and Leitzke, R. C. Z.}, year={2021}, month={jan.}, pages={80–86} }